Abstract
The present invention relates to the field of pharmaceutical sciences and material chemistry. More particularly, the invention relates to novel solid forms of the apolipoprotein L1 (APOL1) inhibitor Inaxaplin, including a novel crystalline form, an amorphous form, novel solvates, and amorphous solid dispersions (ASDs). The invention further provides cost-effective, industrially scalable processes for their preparation and pharmaceutical compositions containing them for treating kidney diseases.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
Venukathala, Prashanth and Prashanth, Venukathala, "SOLID FORMS OF INAXAPLIN, PROCESSES FOR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS THEREOF", Technical Disclosure Commons, ()
https://www.tdcommons.org/dpubs_series/10284